肝细胞癌系统治疗的演变:改变治疗策略和概念
Michihisa Moriguchi1, Seita Kataoka1, Yoshito Itoh1
1Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-0841, Japan.
Cancers
|July 13, 2024
概括
肝细胞癌 (HCC) 的全身治疗正在通过免疫疗法和组合疗法推进. 这些新方法改善了生存率,并为所有阶段的HCC患者提供了手术选择.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 对肝细胞癌 (HCC) 的全身治疗取得了显著进展.
- 免疫疗法,包括阿特佐利祖马布加贝瓦齐祖马布 (ATZ/BEV) 和杜尔瓦卢马布加特梅利卢马布,标志着HCC治疗的新时代.
- 这些进展提高了整体存活率,并允许在特定患者中转换为手术切除.
研究的目的:
- 审查目前所有疾病阶段的HCC全身治疗的现状.
- 讨论新的全身治疗策略,特别是那些涉及免疫检查点抑制剂的策略.
- 探索HCC系统治疗的未来方向.
主要方法:
- 对最近的临床试验和HCC系统治疗进展的审查.
- 专注于组合疗法,包括免疫检查点抑制剂.
- 对针对不同HCC阶段的治疗策略的分析.
主要成果:
- 阿特佐利祖马布加贝瓦齐祖马布 (ATZ/BEV) 已证明有效,特别是在高风险的术后患者 (IMbrave050试验).
- 系统治疗与局部治疗的结合,如通过导管动脉化学栓塞 (TACE),正在研究中期HCC.
- 系统性治疗显示出高响应率,改善了生存率,并使治疗疗法具有治愈意图.
结论:
- 对HCC的全身治疗正在迅速发展,为所有疾病阶段提供了新的选择.
- 免疫疗法和局部疗法的整合有望改善患者的治疗结果.
- 未来的研究很可能会专注于优化这些新的系统性疗法及其组合.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
728
相关概念视频
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509